"Dartmouth Health, New Hampshire's only academic health system and the state's largest private employer, serves patients across northern New England. Dartmouth Health provides access to more than 2,000 providers in almost every area of medicine, delivering care at its flagship hospital, Dartmouth Hitchcock Medical Center (DHMC) in Lebanon, NH, as well as across its wide network of hospitals, clinics and care facilities. DHMC is consistently named the #1 hospital in New Hampshire by U.S. News & World Report, and recognized for high performance in numerous clinical specialties and procedures."

During the past decade, Dartmouth Hitchcock Medical Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dartmouth Hitchcock Medical Center" #1 sponsor was "Vertex Pharmaceuticals Incorporated" with 3 trials, followed by "Dartmouth-Hitchcock Medical Center" with 2 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored, "Hoosier Cancer Research Network" with 1 trials sponsored and "Proteostasis Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dartmouth Hitchcock Medical Center" #1 collaborator was "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bionomics Limited" with 1 trials as a collaborator, "Dartmouth College" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Dartmouth Hitchcock Medical Center" are "Cystic Fibrosis" (4 trials), "Cutaneous Melanoma" (1 trials), "Diabetes Mellitus" (1 trials), "Heart Failure" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "Dartmouth Hitchcock Medical Center" in a lesser frequency.

Most popular intervention types in "Dartmouth Hitchcock Medical Center" are "Drug" (7 trials), "Other" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "IVA" (3 trials), "Annotated Audio" (1 trials), "Audio" (1 trials), "Audio recording" (1 trials) and "BNC105P" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dartmouth Hitchcock Medical Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Dartmouth Hitchcock Medical Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Dartmouth Hitchcock Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dartmouth Hitchcock Medical Center, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".